With the latest funding round, Blood Cancer United's cumulative research funding tops $2 billion, continuing to help increase survival rates and improve patients' lives Blood Cancer United's new ...

Heart disease and cancer were again the leading causes of death in the U.S. in 2024, according to a CDC report published Sept. 10, which analyzed 99.9% of 2024 death records as of June 1, 2025. At the ...

The state of prostate cancer in the U.S. is not exactly great. Just take a look at the “Prostate cancer statistics, 2025” report from the American Cancer Society, published at the beginning of ...

In the high-stakes arena of cancer drug development, SU212 was engineered as a safer twist on podophyllotoxin—a toxic killer designed to halt rogue cell division. Yet in a twist worthy of scientific ...

Pancreatic cancer survival has finally doubled in a decade to 13 percent, a fragile but real sign that years of slow, methodical progress are beginning to add up. November is Pancreatic Cancer ...